Pay in 4 interest-free payments of $7.19 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Similarly, a retrospective cohort trial, published in 2025, which included over 295,000 patients from North America, reported GLP1RA use was associated with about a 70% lower risk of incident dementia vs nonuse (HR = 0.30), significant even after statistical matching and multivariable adjustments [20]
(usually a year or more!) Not confirmed by purchase Not confirmed by purchase
Eur J Pharm Biopharm
Anaerobe 14(1):4348
More may follow research from the Business Group on Health found 10% of companies that now cover GLP-1s for weight-loss plan to drop them by 2027
The authors declare that all other data supporting the findings of this study are available within the article and Supplementary Information files, and also are available from the corresponding author upon reasonable request
US$ 22.44
US$ 20.24
US$ 20.51
US$ 27.23
